Real-Time Ultrasonography-Computed Tomography Fusion Imaging for Staging of Hepatic Metastatic Involvement in Patients With Colorectal Cancer: Initial Results From Comparison to US Seeing Separate CT Images and to Multidetector-Row CT Alone

Objectives:To prospectively evaluate the role of real-time ultrasonography (US)-computed tomography (CT) fusion imaging (US-CT) in comparison with US seeing separate CT images (US + CT) and multidetector-row CT (MDCT) for the correct staging of hepatic metastatic involvement in patients with colorectal cancer. Methods:Sixty-four patients with newly diagnosed colorectal cancer and who were referred for abdominopelvic staging before primary tumor resection underwent same-day MDCT, US + CT, and US-CT. Examinations were evaluated on-site by 2 investigators in consensus. Investigators recorded the size and location of detected lesions on segmental liver maps, classified them as being benign, malignant, or indeterminate, and finally assessed the M stage of the liver as being M0, M1, or Mx (indeterminate). All patients underwent surgical exploration including intraoperative US. Reference standard diagnosis was based on findings at surgery, intraoperative US, histopathology, and MDCT follow-up imaging. Differences among investigated modalities were analyzed using McNemar′s test. Results:The reference standard verified 109 (45 ≤ 1 cm) hepatic lesions in 25 patients, including 65 (25 ≤ 1 cm) metastases in 16 patients (M1). Regarding the 45 ≤ 1 cm liver lesions, rates for detection were significantly higher (P < 0.05) for MDCT (80%, 36/45) and US-CT (77.8%, 35/45) than for US + CT (64.4%, 29/45); the rate for correct classification by US-CT (71.1%, 32/45) was significantly higher than for US + CT (48.9%, 22/45) and MDCT (31.1%, 14/45) (all P < 0.05). On patient-based analysis, specificity of MDCT (85.4%, 41/48) was significantly lower (P < 0.05) than for US-CT (97.9%, 47/48) and US + CT (93.7%, 45/48); the positive predictive value of MDCT (63.1%, 12/19) was not significantly different (P = 0.27) compared with US + CT (82.3%, 14/17) but significantly lower (P < 0.05) than for US-CT (93.7%, 15/16). In 13 patients (59 lesions) with only benign (stage M0) or coexistent benign and malignant lesions (stage M1), indeterminate lesion ratings and indeterminate liver stagings (Mx) occurred both significantly lower (P < 0.05) with US-CT (3.4%, 2/59; and 0%, 0/13) than with US + CT (11.9%, 7/59; and 23.1%, 3/13) or with MDCT (30.5%, 18/59; and 53.8%, 7/13). Conclusions:Based on these initial diagnostic experiences, complementary US-CT fusion imaging of small CT-indeterminate liver lesions may have value in staging patients with colorectal cancer, focusing on patients who were likely to harbor only benign or coexisting benign and malignant liver lesions and in whom change of M staging would change the clinical management.

[1]  J. Hartley,et al.  Is Routine Magnetic Resonance Imaging Justified for the Early Detection of Resectable Liver Metastases From Colorectal Cancer? , 2006, Diseases of the colon and rectum.

[2]  M. Salvatore,et al.  Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents , 2010, Abdominal Imaging.

[3]  Wei Yang,et al.  Focal Liver Lesions: Can SonoVue-Enhanced Ultrasound Be Used to Differentiate Malignant From Benign Lesions? , 2007, Investigative radiology.

[4]  I. Floriani,et al.  Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. , 2007, Clinical radiology.

[5]  Jeong Min Lee,et al.  Detection and characterization of focal hepatic lesions: comparative study of MDCT and gadobenate dimeglumine-enhanced MR imaging. , 2008, Clinical imaging.

[6]  Janice Ward,et al.  Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. , 2005, Radiology.

[7]  G. Lim,et al.  Natural History of Small, “Indeterminate” Hepatic Lesions in Patients with Colorectal Cancer , 2009, Diseases of the colon and rectum.

[8]  C. Bartolozzi,et al.  Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT , 2004, European Radiology.

[9]  Atsushi Hiraoka,et al.  Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography. , 2006, AJR. American journal of roentgenology.

[10]  Carlo Bartolozzi,et al.  Targeting Liver Lesions for Radiofrequency Ablation: An Experimental Feasibility Study Using a CT–US Fusion Imaging System , 2008, Investigative radiology.

[11]  G. Adam,et al.  Comparison of 1.0 M Gadobutrol and 0.5 M Gadopentetate Dimeglumine-Enhanced Magnetic Resonance Imaging in Five Hundred Seventy-Two Patients With Known or Suspected Liver Lesions: Results of a Multicenter, Double-Blind, Interindividual, Randomized Clinical Phase-III Trial , 2009, Investigative radiology.

[12]  W. Mali,et al.  Diffusion-Weighted Magnetic Resonance Imaging of the Liver Using TRacking Only Navigator Echo: Feasibility Study , 2010, Investigative radiology.

[13]  J. Heiken,et al.  Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. , 2003, Radiology.

[14]  N. Major.  Role of MRI in prevention of metatarsal stress fractures in collegiate basketball players. , 2006, AJR. American journal of roentgenology.

[15]  Wilhelm Horger,et al.  Black-Blood Diffusion-Weighted EPI Acquisition of the Liver with Parallel Imaging: Comparison with a Standard T2-Weighted Sequence for Detection of Focal Liver Lesions , 2008, Investigative radiology.

[16]  J. Bloem,et al.  Hepatic metastases in patients with colorectal cancer: relationship between size of metastases, standard of reference, and detection rates. , 2002, Radiology.

[17]  Wolfgang Schima,et al.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions , 2009, European Radiology.

[18]  I. Lande,et al.  The mistaken or indeterminate CT diagnosis of hepatic metastases: the value of sonography. , 1987, AJR. American journal of roentgenology.

[19]  W. Chapman,et al.  MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility. , 2007, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[20]  C. Bokemeyer,et al.  A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. , 2009, European journal of cancer.

[21]  Ying Lu,et al.  Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. , 2002, Radiology.

[22]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[23]  E. Leen,et al.  Radiological staging of colorectal liver metastases. , 2007, Surgical oncology.

[24]  S. Eberhardt,et al.  Utility of Sonography for Small Hepatic Lesions Found on Computed Tomography in Patients With Cancer , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[25]  Joon Koo Han,et al.  Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Differentiating Small Hepatocellular Carcinomas (≤2 cm in Diameter) From Arterial Enhancing Pseudolesions: Special Emphasis on Hepatobiliary Phase Imaging , 2010, Investigative radiology.

[26]  R. Kane,et al.  Intraoperative US of the liver: techniques and clinical applications. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[27]  D. Wilson,et al.  Small "indeterminate" lesions on CT of the liver: a follow-up study of stability. , 2003, The British journal of radiology.

[28]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[29]  A. Zwinderman,et al.  Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. , 2005, Radiology.

[30]  Reto Meuli,et al.  Detection of liver metastases under 2 cm: comparison of different acquisition protocols in four row multidetector-CT (MDCT) , 2005, European Radiology.

[31]  Kazuma Fujimoto,et al.  Radiofrequency Ablation with the Real-Time Virtual Sonography System for Treating Hepatocellular Carcinoma Difficult to Detect by Ultrasonography , 2006, Journal of clinical biochemistry and nutrition.

[32]  A. Stang,et al.  Sonographic characteristics of a dermoid cyst -- correlation with CT by use of real-time image fusion. , 2006, Ultraschall in der Medizin.

[33]  Takamichi Murakami,et al.  Effectiveness of real‐time virtual sonography‐guided radiofrequency ablation treatment for patients with hepatocellular carcinomas , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[34]  E. Merkle,et al.  Field Strength and Diffusion Encoding Technique Affect the Apparent Diffusion Coefficient Measurements in Diffusion-Weighted Imaging of the Abdomen , 2010, Investigative radiology.

[35]  Won J. Lee,et al.  Small Hypoattenuating Lesions in the Liver on Single-phase Helical CT in Preoperative Patients With Gastric and Colorectal Cancer: Prevalence, Significance, and Differentiating Features , 2002, Journal of computer assisted tomography.

[36]  S. E. Lind,et al.  Diagnosing liver metastases: a Bayesian analysis. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  D. Wilson,et al.  Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings. , 2001, Clinical radiology.

[38]  L. Schwartz,et al.  Prevalence and importance of small hepatic lesions found at CT in patients with cancer. , 1999, Radiology.

[39]  P. Karhunen.  Benign hepatic tumours and tumour like conditions in men. , 1986, Journal of clinical pathology.

[40]  M Birth,et al.  [Ultrasound-guided interventions using magnetic field navigation. First experiences with Ultra-Guide 2000 under operative conditions]. , 2003, Ultraschall in der Medizin.

[41]  E M Jung,et al.  New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results. , 2009, Clinical hemorheology and microcirculation.

[42]  J. Krücker,et al.  Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. , 2007, Journal of vascular and interventional radiology : JVIR.

[43]  M. Langer,et al.  Detection and characterization of benign focal liver lesions with multislice CT , 2006, European Radiology.

[44]  L. Jönsson,et al.  Health-economic evaluation of three imaging strategies in patients with suspected colorectal liver metastases: Gd-EOB-DTPA-enhanced MRI vs. extracellular contrast media-enhanced MRI and 3-phase MDCT in Germany, Italy and Sweden , 2009, European Radiology.

[45]  Nassir Navab,et al.  Automatic CT-ultrasound registration for diagnostic imaging and image-guided intervention , 2008, Medical Image Anal..

[46]  Masatoshi Kudo,et al.  Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. , 2008, AJR. American journal of roentgenology.

[47]  J A Molloy,et al.  Benchmarking a novel ultrasound-CT fusion system for respiratory motion management in radiotherapy: assessment of spatio-temporal characteristics and comparison to 4DCT. , 2007, Medical physics.

[48]  U. Motosugi,et al.  Imaging of Small Hepatic Metastases of Colorectal Carcinoma: How to Use Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging in the Multidetector-Row Computed Tomography Age? , 2009, Journal of computer assisted tomography.

[49]  Jae Young Lee,et al.  Value of Dual Contrast Liver MRI at 3.0 T in Differentiating Well-Differentiated Hepatocellular Carcinomas From Dysplastic Nodules: Preliminary Results of Multivariate Analysis , 2009, Investigative radiology.

[50]  V. Runge.  Advances in magnetic resonance. , 2004, Investigative radiology.

[51]  V. Runge.  Advances in Magnetic Resonance (2009) , 2009, Investigative radiology.

[52]  J. Figueras,et al.  Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. , 2001, Radiology.

[53]  C. Claussen,et al.  Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping—Initial Clinical Experiences in Comparison to PET-CT , 2007, Investigative radiology.

[54]  Yuman Fong,et al.  Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  T. Baère,et al.  Incidence of Unsuspected and Treatable Metastatic Disease Associated With Operable Colorectal Liver Metastases Discovered Only at Laparotomy (and Not Treated When Performing Percutaneous Radiofrequency Ablation) , 2005, Annals of Surgical Oncology.

[56]  M. Haider,et al.  Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better? , 2002, Radiology.

[57]  A. Loft,et al.  Contrast-enhanced FDG-PET/CT vs. spio-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation , 2007, Acta radiologica.

[58]  M. Bosio,et al.  Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) - Update 2008 , 2008, Ultraschall in der Medizin.

[59]  Hepatic Computed Tomography for Simultaneous Depiction of Hepatocellular Carcinoma, Intrahepatic Portal Veins, and Hepatic Veins in Real‐time Virtual Sonography , 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[60]  T. Murakami,et al.  Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. , 2006, Radiology.

[61]  Jae Young Lee,et al.  Diagnostic Performance of Multidetector Row Computed Tomography, Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging, and Dual-Contrast Magnetic Resonance Imaging in Predicting the Appropriateness of a Transplant Recipient Based on Milan Criteria: Correlation With Histopathological Find , 2009, Investigative radiology.

[62]  T. Murakami,et al.  Detection and Characterization of Focal Liver Lesions: A Japanese Phase III, Multicenter Comparison Between Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging and Contrast-Enhanced Computed Tomography Predominantly in Patients With Hepatocellular Carcinoma and Chronic Liver Disease , 2010, Investigative radiology.

[63]  S. Park,et al.  Small (, 2004, AJR. American journal of roentgenology.

[64]  Michael A Choti,et al.  Expanding criteria for resectability of colorectal liver metastases. , 2008, The oncologist.

[65]  R. Parks,et al.  Guidelines for resection of colorectal cancer liver metastases , 2006, Gut.

[66]  Sukru Mehmet Erturk,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Characterization of Focal Liver Masses: Impact of Parallel Imaging (SENSE) and b Value , 2008, Journal of computer assisted tomography.